The hair follicle (HF) represents a hair shaft-producing mini-organ that shows cyclic activity during postnatal development, with periods of relative resting (telogen), active growth and hair shaft production (anagen), and apoptosis-driven regression (catagen) (1) (2) (3) . This cyclic activity of the HF is governed by the epithelial-mesenchymal interactions between HF keratinocytes and fibroblasts of the dermal papilla. The HF transition between distinct hair cycle stages is regulated by a tightly controlled balance between numerous growth stimulatory and inhibitory factors (1-3).
The HF transition from telogen to anagen is a unique process of organ regeneration characterized by sudden activation of cell proliferation in the proximal follicular epithelium (secondary hair germ and bulge) containing HF stem cells (4 -7) . This leads to invasion of the elongating HF into subcutaneous (s.c.) tissue that is accompanied by reactivation of cell differentiation programs, followed by construction of the hair matrix and inner root sheath (3), as well as by differentiation of melanocyte precursors leading to melanogenesis (8 -10) . Full restoration of the hair fiber-producing unit is associated with formation of the epithelial hair bulb surrounding the dermal papilla located deep in the s.c. tissue (1) (2) (3) .
Induction of cell proliferation in the germinative compartment of the telogen HF leading to anagen development can be induced experimentally by mechanical or chemical stimuli. For example, mechanical removal of the hair shaft (depilation) induces anagen in mice and humans (1, 3, 11, 12) . Abnormal shedding of hair in mouse mutants with constitutive deletion of the adhesion molecule desmoglein-3 or proteolytic enzyme L-cathepsin also induces anagen (13, 14) . Deletion of STAT3 transcription factor is associated with a long-term delay of the hair follicles in telogen (15) . Chemical stimulation of a variety molecular pathwayse.g., immunosuppressants (cyclosporin A, FK506), a potassium channel opener (minoxidil), neuropeptides (substance P, ACTH), mast cell secretagogues, or an estrogen receptor antagonist-results in anagen induction (16 -20) . This suggests that the local balance of hair growth stimulators and inhibitors in the proximal part of the HF (bulge, secondary hair germ, dermal papilla) is critical for initiation of a new hair growth wave.
Since HF morphogenesis and anagen development have many similarities and both result in construction of the fiber-producing hair bulb, it has long been suspected that both processes are regulated by similar mechanisms (1-3, 21, 22) . This concept was recently supported by demonstrating that Sonic hedgehog (Shh) is a factor controlling both HF development and telogen-anagen transition. Shh is an essential epithelial signal that promotes HF morphogenesis in embryonic skin. Constitutive deletion of Shh results in the arrest of HF morphogenesis at the bud stage (23, 24) , whereas the overexpression of Shh or its downstream effector Gli2 induces basal cell carcinoma development (25, 26) . It was recently demonstrated that increased intradermal expression of Shh stimulates HF transition from telogen to anagen (27) . Conversely, Shh blockade by neutralizing antibody alters HF transition from telogen to anagen in the postnatal skin (28) .
It was proposed some time ago that telogen skin contains an inhibitor of hair growth and that neutralization or inactivation of this inhibitor might trigger HF transition from telogen to anagen in postnatal skin (12) . Bone morphogenetic proteins 2 and 4 (BMP2/4) inhibit induction of many ectodermal derivatives such as the neural tube, tooth, or feather during embryogenesis (29 -32) . We have recently shown that neutralization of the inhibitory activity of BMP2/4 by the BMP antagonist noggin is also essential for HF induction (33) . Therefore, we hypothesized that, as in HF induction during embryogenesis, BMP2/4 serve as important inhibitor of anagen initiation in postnatal skin and that neutralization of BMP4 by its antagonist noggin is required for the HF telogen-anagen transition.
To explore the roles for noggin and BMP4 in the control of HF transition from telogen to anagen, we analyzed the expression of BMP4, BMPR-IA, and noggin during the depilation-induced hair cycle in the postnatal C57BL/6 mice using semiquantitative RT-PCR, in situ hybridization, and immunohistology. The hair growth-modulatory activities of noggin and BMP4 were also tested in vivo. In addition, the expression of the selected molecules implicated in the control of the telogen-anagen transition was compared between noggin-and/or BMP4-treated skin and the corresponding controls. Using this experimental approach, we demonstrate here that neutralization of the inhibitory activity of BMP4 by the BMP antagonist noggin indeed initiates a new hair growth phase in postnatal skin.
MATERIALS AND METHODS

Animal models and tissue collection
Eight-week-old C57BL/6J female mice were purchased from Charles River (Boston, MA). Mice were housed in community cages at the animal facilities of the Boston University School of Medicine. Heterozygous noggin knockout (Ϯ) mice (33) (34) (35) (36) were used to determine noggin expression in postnatal spontaneously cycling HF by histoenzymatic staining cryosections with ␤-galactosidase. All mice were fed water and murine chow ad libitum and kept under 12 h light/dark cycles. Active hair growth (anagen) was induced in the back skin during the telogen phase of the hair cycle by application of the wax-rosin mixture with subsequent depilation, as described before (12) . HF telogen-anagen transformation was studied using at least four mice per time point: telogen (unmanipulated skin), early anagen (day 3 postdepilation), late anagen (days 8 -12 postdepilation) (12) . In all experiments, the neck region of back skin was harvested parallel to the vertebral line and was embedded, using a special technique for obtaining longitudinal cryosections through the HF from one defined site (37) .
Semiquantitative RT-PCR
Semiquantitative RT-PCR analysis of noggin, BMP4, BMPR-IA, and constitutively expressed ␤-actin was performed as described previously (38 -40) . Total RNA was isolated from full-thickness back skin samples of C57BL/6 mice harvested at telogen (unmanipulated skin), early anagen (3 days postdepilation), and late anagen (8 -12 days postdepilation) stages of the hair cycle. Skin was homogenized in liquid nitrogen using a mortar and total RNA was isolated using a single step guanidine thiocyanate-phenol-chloroform method with RNAzol B (Biotech Laboratories, Inc., Houston, TX). cDNA was synthesized by reverse transcription of 3 g total RNA, using a cDNA synthesis kit (Invitrogen, San Diego, CA). The following sets of oligonucleotide primers were used: for ␤-actin, 5Ј-TGG AAT CCT GTG GCA TCC ATG AAA C-3Ј and 5Ј-TAA AAC GCA GCT CAG TAA CAG TCC G-3Ј; for noggin, 5Ј-GAA GGA TCT GAA CGA GAC GC-3Ј and 5Ј-TTA CAC TCG GAA ATG ATG G-3Ј; for BMP4, 5Ј-CTC CCA AGA ATC ATG GAC TG-3Ј and 5Ј-AAA GCA GAG CTC TCA CTG GT-3Ј; for BMPR-IA, 5Ј-AGA AGC TAG CTG GTT TAG AG 3Ј and 5Ј-ATT AGC TTC AAA ACT GCT CG-3Ј. Primers used were designed according to the reported sequences in the GenBank databases. Amplification was performed using Taq polymerase (Life Technologies, Inc., Grand Island, NY) over 34 cycles, using an automated thermal cycler (Perkin-Elmer Corp., Norwalk, CT). Each cycle consisted of the denaturing at 94°C (1 min), annealing at 60°C (45 s), and extension at 72°C (45 s). PCR products were analyzed by agarose gel electrophoresis and enzymatic digestion using standard methods. Staining was densitometrically assessed with video scanner using Scan Pack 2.0 (Biometra, Goettingen, Germany).
In situ hybridization and immunohistochemistry
In situ hybridization using Dig-labeled riboprobes for noggin, BMP4, and Shh mRNAs was performed as described (23, 33, 41) . Skin cryosections of 8-to 12-wk-old LacZ heterozygous noggin knockout (Ϯ) females (nϭ4) were used for analyses of noggin expression in postnatal HF by histoenzymatic ␤-galactosidase staining, as described previously (33) (34) (35) (36) . Immunohistochemical detection of bone morphogenetic protein receptor IA (BMPR-IA), Lef-1, and Ki-67 was performed according to described protocols (38 -40, 42) . Rabbit antisera for Lef-1 and BMPR-1A were generated, as described (43, 44) . Rabbit antiserum against murine Ki-67 was obtained from Dianova (Hamburg, Germany). Secondary goat anti-rabbit TRITC-conjugated immunoglobulin G (IgG) was obtained from Jackson Immuno-Research (West Grove, PA). In all immunofluorescence procedures, nuclei were counterstained by TO-PRO-3 (45) . Multicolor confocal microscope (Zeiss, Thornwood, NY) and digital image analysis system (Pixera, Los Gatos, CA) were used for analysis and preparation of images.
Pharmacological manipulations in vivo
Noggin protein was isolated from the supernatants of nogginproducing CHO B3.A4 cells as described previously (29); 200 l of Affi-gel blue beads (Bio-Rad, Hercules, CA; 100 m in diameter) were soaked with 200 l of mouse normal serum (control) or 200 l of 10 g/ml noggin (33) . Beads were then injected into the back skin of mice, with all HF in the resting stage (nϭ7 for the control group and nϭ7 for the group treated with noggin), as identified by their pink back skin color (33) . Skin was harvested on days 5-18 after implantation.
Recombinant human BMP4 was expressed in Escherichia coli with a carboxyl-terminal His Tag using a modified pQE Vector (Qiagen, Chatsworth, CA) and purified under denaturing conditions on Ni-NTA Agarose (Qiagen). BMP4 was dimerized as described (N. Cerletti et al., European Patent Application 0433 225 A1; June 19, 1991 ) and the protein concentration was determined by SDS-PAGE; 100 l of BMP4 in concentration 1 g/ml was injected intradermally on days 0, 1, 3, and 5 postdepilation (nϭ5 for the experimental group and nϭ4 for the control group). Skin was harvested on day 12 postdepilation (i.e., 7 days after the last injection), when all depilated control HF had reached late anagen.
Quantitative histomorphometry
In the skin samples treated by BMP4 or noggin, the percentage of HF at defined hair cycle stages (telogen, anagen II, anagen VI) was assessed and defined on the basis of accepted morphological criteria (16, 46) . To identify the defined substages of hair cycle as precisely as possible, histochemical detection of endogenous alkaline phosphatase activity was used, as this highlights the dermal papilla as a useful morphological marker for staging HF anagen development (47) . For every in situ hybridization or immunoreactivity pattern, Ͼ150 hair follicles derived from three animals per hair cycle stage were examined. In pharmacological experiments, at least 50 -60 longitudinal HF sections in 50 -60 microscopic fields derived from 4 -5 BMP4-treated animals were analyzed and compared with those of 50 -60 HF for the corresponding control group. All sections were analyzed at 100 or 200ϫ microscopic magnification; means and se were calculated from pooled data. Differences were judged as significant if the P value was Ͻ0.05, as determined by the independent Student's t test for unpaired samples.
RESULTS
Hair growth phase induction in postnatal skin is associated with up-regulation of noggin
To explore whether noggin and BMPs are involved in the control of the HF transition from telogen to anagen, noggin, BMP4, and BMPR-IA gene transcription in full-thickness mouse skin was characterized by semiquantitative RT-PCR analysis during the induced, highly synchronized hair cycle in C57BL/6J mice. In situ hybridization for noggin and BMP4, as well as immunohistology for BMPR-IA, were performed to characterize their expression during the depilationinduced hair cycle.
By semiquantitative RT-PCR, high steady-state levels of BMP4 and BMPR-IA were detected in telogen skin, whereas very low levels of noggin transcripts were found ( Fig. 1A-C) . Hair follicle transition from telogen to late anagen was associated with significant up-regulation (PϽ0.05) of steady-state levels of noggin transcripts (Fig. 1B) . However, steady-state levels of BMP4 and BMPR-IA mRNAs in anagen skin remained as high as in telogen and were not changed significantly (Fig. 1A, C) .
BMP4 transcripts were found in the dermal papilla by in situ hybridization in the secondary hair germ of telogen HF ( Fig. 2A) . Dermal cells also showed BMP4 mRNA expression in telogen skin ( Fig. 2A) . Noggin message was absent in telogen HF (Fig. 2B) . However, weak expression of noggin mRNA was visible in few Figure 1 . Semiquantitative RT-PCR for BMP4, noggin, and BMPR-IA during induced hair cycle. C57BL/6 mouse back skin of the defined hair cycle stages (telogen; unmanipulated skin, anagen II-III ϭ 3 days after anagen induction by depilation, anagen VI ϭ 8 -12 days after anagen induction) was processed for semiquantitative RT-PCR of BMP4, noggin, and BMPR-IA. At defined time points, total RNA was extracted from full-thickness back skin, including the panniculus carnosus muscle; RNA was reverse transcribed and semiquantiative RT-PCR was performed using primers specific for BMP4 (A), noggin (B), BMPR-IA (C), and ␤-actin (D). Representative gels from one of three experiments each (day 0, telogen; days 3 and 8, early and late anagen, respectively). Densitometric analysis of RT-PCR signals specific for BMP4 (A), noggin (B), BMPR-IA (C), and ␤-actin (D); means Ϯ sd, n ϭ 3:* P Ͻ 0.05. dermal cells (Fig. 2B) , which is consistent with the semiquantitative RT-PCR results (Fig. 1B) . In heterozygous noggin knockout (Ϯ) mice, the lack of noggin in telogen HF was further supported by the absence of ␤-galactosidase activity (the gene product partially replaced noggin in these animals; Fig. 2C ). In contrast to noggin, strong BMPR-IA immunoreactivity was seen in the secondary hair germ, sebaceous gland, and arrector pili muscle (Fig. 2D, E) . The expression patterns for BMP4, BMPR-IA, and noggin described above were seen in all hair follicles examined.
Early steps of the HF telogen-anagen transition (anagen I-III, 3 days postdepilation) were associated with down-regulation of BMP4 transcripts in the dermal papilla and secondary hair germ (Fig. 2F) . However, many dermal cells showed BMP4 mRNA expression in early anagen skin (Fig. 2F) . In early anagen HF, noggin mRNA was seen not only in the dermal papilla, but also in the secondary hair germ and distal outer root sheath (Fig. 2G) . The appearance of ␤-galactosidase activity in the secondary hair germ and dermal papilla of early anagen HF of LacZ heterozygous noggin knockout (Ϯ) mice (Fig. 2H) confirmed the latter results. This suggested that in postnatal skin, noggin expression is not restricted to follicular mesenchyme and can also be seen in the epithelium. However, BMPR-IA immunoreactivity was undetectable in the secondary hair germ (Fig. 2I) , previously reported to have numerous proliferating cells during early anagen (48) . Instead, BMPR-IA was seen in those HF compartments that show a very low proliferative activity during anagen (dermal papilla, distal outer root sheath; Fig. 2I ). These data do not contradict the overall constant total expression of mRNA transcripts observed by RT-PCR in whole skin homogenates.
During late anagen (days 8 -12 postdepilation), BMP4 transcripts were seen in the proximal hair matrix, dermal papilla, and outer and inner root sheaths of fully developed anagen HF (Fig. 2K ). Prominent expression of noggin mRNA was observed in the entire cycling portion of the anagen HF (hair matrix, dermal papilla, proximal outer and inner root sheaths; Fig.   Figure 2 . Hair follicle telogen-anagen transition is associated with up-regulation of noggin. C57BL/6 mouse back skin ofthe defined hair cycle stages (telogen, unmanipulated skin; anagen II-III ϭ 3 days after anagen induction by depilation, anagen VI ϭ 8 -12 days after anagen induction) was processed for in situ hybridization and immunohistological analyses of BMP4, noggin, and BMPR-IA. Noggin expression was also assessed by ␤-galactosidase activity of skin cryosections of LacZ heterozygous noggin knockout (Ϯ) mice (C, H). In situ hybridization and immunoreactivity patterns for BMP4, noggin, and BMPR-IA in telogen, early and late anagen hair follicles are schematically summarized in panels E, J, and N. Telogen skin (A-E). A) BMP4 mRNA expression in dermal papilla (arrow), single cells of the secondary hair germ (small arrowhead), and the distal outer root sheath (small arrowhead) of the non-tylotrich HF (sebaceous gland is indicated by asterisk). BMP4 signals in dermal cells are indicated by large arrowheads. Absence of noggin mRNA (B) and ␤-galactosidase activity (C) in the telogen HF (dermal papillae, secondary hair germs, and sebaceous glands are indicated by an arrow, arrowhead, and asterisk, respectively). Weak noggin signal is present in dermal cells (B, large arrowhead). D) BMPR-IA immunoreactivity in the secondary hair germ (small arrowhead), the arrector pili muscle (large arrowhead), and the sebaceous gland (asterisk). Dermal papilla is indicated by arrow. Early anagen skin (F-J). F) Down-regulation of BMP4 mRNA in the secondary hair germ (small arrowhead) and in the dermal papilla (arrow) of early anagen HF. BMP4 signals in dermal cells are indicated by large arrowheads. G, H) Appearance of noggin mRNA (G) and ␤-galactosidase activity (H) in the secondary hair germ (small arrowheads) and dermal papillae (arrows) of early anagen HF (sebaceous glands are indicated by asterisks). Noggin signal is also visible in dermal cells (G, large arrowhead). I) BMPR-IA in the dermal papilla (arrows), cells located close to the club hair (large arrowheads). Lack of the BMPR-IA in the secondary hair germ (small arrowheads). Late anagen (K-N). K) Expression of BMP4 mRNA in the proximal outer root sheath (large arrowheads), inner root sheath (small arrowhead), hair matrix (large arrows), and dermal papilla (small arrow) of late anagen HF. L) Expression of noggin mRNA in the hair matrix (Fig. 1B) . In addition, many mesenchymal cells in the perifollicular dermis and subcutis around late anagen HF also showed noggin mRNA expression (Fig. 2L) . BMPR-IA immunoreactivity was seen in the hair matrix and in proximal outer and inner root sheaths of late anagen HF (Fig. 2M, N) . Therefore, hair cycle-associated expression patterns of BMP4, noggin and BMPR-IA suggested involvement of BMP signaling in the control of epithelial-mesenchymal interactions in the HF during its transition from telogen to anagen.
Noggin induces hair growth phase in postnatal skin in vivo
To correlate the phenomenological data described above (Fig. 1, Fig. 2 ) with the putative functional effects of noggin on the HF telogen-anagen transition, agarose beads soaked by noggin or by normal mouse serum as a control were injected into C57BL/6J telogen skin. The beads provided long-term release of the noggin in close proximity to telogen HF, and skin was studied 5-18 days after implantation. Apparent skin color in mice is strikingly dependent on the hair cycle stage and varies from white-pink in telogen to grayblack in anagen, reflecting the stringent coupling of follicular melanogenesis to anagen (46, 49, 50) . Therefore, anagen development was monitored by assessing the dynamics of skin color changes in a previously shaven telogen skin, as well as by the emergence of new pigmented hair shafts through the epidermis.
As shown in Fig. 3A , noggin-treated (but not control) animals displayed anagen induction in those areas where beads had been implanted with a change of skin color to gray-black and in the emergence of new pigmented hair from the skin surface. Histological analysis confirmed that noggin-induced anagen development occurred both in tylotrich and non-tylotrich HF. In the immediate vicinity of the noggin-soaked beads, only anagen VI HF-producing pigmented hair was seen (Fig. 3C) . In contrast, in skin areas 2-3 mm distant from the implanted beads, earlier anagen stages (anagen II-IV HF) were also seen (not shown). No anagen development was found in skin areas located at a distance of more than 3 mm from the noggin-soaked beads (not shown); no anagen development at all was observed in the control animals, which displayed only telogen HF (Fig. 3A, B) .
BMP4 induces selective arrest of hair growth phase development in the secondary (non-tylotrich) hair follicles
To test whether BMP4 inhibits anagen development in postnatal skin, the effects of BMP4 administration on depilation-induced HF telogen-anagen transition were assessed. BMP4 or vehicle control was administered intracutaneously on days 0, 1, 3, and 5 after depilation, and skin was examined 7 days after the last administration, i.e., on day 12 postdepilation. As shown in Fig. 4A , control mice displayed new fur, indicating that all HF reached anagen VI (Fig. 4B) . However, BMP4-treated animals showed only a few anagen spots and the skin remained white-pink in color, indicating arrest of anagen development (Fig. 4A ). BMP4-treated skin showed selective arrest of depilation-induced anagen development in all non-tylotrich (secondary) HF (Fig. 4C, D) .
Non-tylotrich HF represent ϳ90% of follicles in mouse fur and are identified by the smaller size of the proximal hair bulb, shorter and thinner hair, and one sebaceous gland (51) . After BMP4 treatment, all nontylotrich HF were arrested in telogen-anagen I, whereas all non-tylotrich HF in the control skin reached anagen VI (Fig. 4C) . In contrast, BMP4 did not affect anagen development in the tylotrich (primary) HF. Tylotrich HF represent ϳ5-10% in mouse fur and are characterized by two sebaceous glands, larger volume of the proximal hair bulb, and longer and thicker hair (51) . On day 12 after depilation and 7 days after last administration of BMP4, all tylotrich HF, similar to the control, reached anagen VI (Fig. 4C, D) .
Furthermore, tylotrich HF showed a high number of Ki-67-positive cells in the hair matrix (Fig. 4E) , a characteristic feature of the late anagen HF (2, 3). However, non-tylotrich HF had Ki-67-positive cells only in the distal outer root sheath and did not show proliferating cells in the secondary hair germ (Fig. 4E ). This suggests that BMP4 selectively inhibits cell proliferation in the germinative compartment of the nontylotrich HF, leading to the arrest of anagen development in this HF type.
Noggin increases Shh expression in the HF whereas BMP4 down-regulates Shh
To further explore mechanisms that may involve the reciprocal modulation of anagen development by noggin and BMP4, the expression of markers implicated in the control of both HF induction and hair growth phase initiation was determined in skin treated with noggin, BMP4, or corresponding vehicle controls. Because administration of Shh cDNA in an adenovirus vector induces new hair growth in postnatal telogen skin (27) , Shh mRNA expression was examined. Lef-1 as a downstream effector of Wnt/␤-catenin pathway was also studied because of its expression in the bulge of the telogen HF (52) and because Lef-1 is down-regulated by BMP4 and up-regulated by noggin in embryonic and postnatal HF (33, 36) .
The expression of these markers was compared between skin samples in which anagen development had been induced by depilation (control telogen/anagen I and anagen VI, days 1 and 12 postdepilation, respectively), the samples treated with BMP4 that show selective arrest of telogen-anagen transition and anagen development in the non-tylotrich HF and apparently normal anagen VI tylotrich HF, and samples treated with noggin-soaked agarose beads that display exclusively anagen VI HF (Fig. 5) . Expression of Shh mRNA was slightly above background in the secondary hair germ and distal outer root sheath of the control telogen/anagen I HF (Fig.  5A) . After BMP4 treatment, Shh expression was not seen in the non-tylotrich HF at telogen/anagen I stage (Fig. 5C ). In the control anagen VI HF, Shh transcripts were seen in a unilateral cluster of matrix cells (Fig.  5B) , displaying the characteristic expression pattern described previously (53) . After BMP4 treatment, expression of Shh mRNA was strongly down-regulated in the matrix of tylotrich anagen VI HF (Fig. 5C ). In turn, the noggin-treated non-tylotrich HF showed ectopic bilateral expression of Shh transcript throughout the entire HF matrix (Fig. 5D) .
The downstream effector of Wnt/␤-catenin signaling, the transcription factor Lef-1, was seen in the dermal papilla and secondary hair germ of the control telogen/anagen I HF (Fig. 5E) , as well as in the precortical zone and hair matrix of the control anagen 
in the back skin of 8-wk-old C57BL/6 mice; BMP4 or vehicle control were administered intracutaneously on days 0, 1, 3, and 5 after depilation. Skin was harvested 12 days postdepilation (on day 7 after last administration of BMP4). Cryostat sections were processed for the determination of endogenous alkaline phosphatase (B, D) or immunostained with antiserum against proliferative marker Ki-67 (E). A) Control mouse shows appearance of new fur in the entire back (large arrowhead), whereas BMP4-treated mice display no emerging of new hair through the epidermis of back skin (arrows), except of few small areas of anagen development (small arrowheads). B) Only late anagen HF produced pigmented hair are seen in the control skin (arrows). C) Percentage of the tylotrich and non-tylotrich HF reached anagen VI was compared between the control and BMP4-treated skin (meanϮse, nϭ4 -5 animals per group, Student t test; asterisk indicates significant differences from the vehicle control, ***PϽ0.001). D) Selective inhibition of anagen in the non-tylotrich HF (large arrowheads) showed one sebaceous gland (asterisks). Anagen development in the tylotrich HF (arrow) having two sebaceous glands (small arrowheads) is apparently normal. E) Numerous proliferating cells in the hair matrix of the primary HF (arrow). Absence of proliferating cells in the follicular germinative compartment of the secondary HF (large arrowheads). In the distal outer root sheath of the secondary HF, Ki-67-positive cells are indicated by small arrowheads. Abbreviations: DER, dermis; EP, epidermis. Scale bars: 100 m.
VI HF (Fig. 5F) . Also, weak Lef-1 immunoreactivity was seen in the dermal papilla of these HF (Fig. 5F) . Compared with the control, no alterations in Lef-1 immunoreactivity were seen in the non-tylotrich telogen/anagen I HF treated by BMP4 (not shown). However, the dermal papilla of the tylotrich anagen VI HF after BMP4 treatment displayed an increase in Lef-1 expression (Fig. 5G) . Neither BMP4 nor noggin affected Lef-1 immunoreactivity in the precortical zone or hair matrix of anagen VI HF (Fig. 5G, H) . This suggests that Lef-1 as a transcriptional effector in the Wnt pathway is not involved in the telogen-anagen transition and that modulation of anagen development by BMP4 and noggin in vivo is mediated, at least in part, by Shh.
DISCUSSION
HF transformation from resting phase to the active hair shaft production is a process of organ regeneration that is governed by inductive epithelial-mesenchymal interactions between keratinocytes of the bulge/secondary hair germ and fibroblasts of the dermal papilla (2, 3) . Here we demonstrate that, in striking similarity to HF morphogenesis (33) , initiation of the active growth stage (anagen) in the resting (telogen) HF requires modulation of BMP4/BMPR-IA signaling by noggin.
In the telogen HF, BMP4 is produced by both dermal papilla fibroblasts and secondary germ keratinocytes and might interact with BMPR-IA, which is selectively expressed in the secondary germ (Fig. 2) , thus preventing the onset of anagen development. Secondary hair germ keratinocytes in murine telogen hair follicles also express Smad1, a signal transduction effector for BMPR-IA (D. Lange et al., unpublished results). This suggests that the BMPR-IA expressed in telogen HF is functional. We further show that activation of hair growth phase in the postnatal telogen HF is associated with up-regulation of noggin in the HF epithelium and mesenchyme (Fig. 2) . Since noggin binds the BMP4 molecule with an affinity 10-to 15-fold higher than does BMPR-IA (54), the locally produced noggin might prevent BMP4 interaction with BMPR-IA expressed in the secondary HF germ of the telogen HF.
Indeed, we show that noggin induces active hair growth in postnatal telogen skin in vivo (Fig. 3) . In contrast, BMP4 plays important inhibitory roles during the HF telogen-anagen transition. BMP4 and BMPR-IA are down-regulated in the germinative compartment of the early anagen HF (Fig. 2) , which is characterized by a high rate of keratinocyte proliferation (48) . Furthermore, BMP4 administration blocks both the depilationinduced anagen development and keratinocyte proliferation in the secondary hair germ of the non-tylotrich (secondary) HF (Fig. 4) . These results fully support a previous report that postnatal telogen skin contains endogenous inhibitor (s) of anagen development or so-called chalone(s) (12) and identify BMP4 as one of these inhibitors.
However, BMP4 administration does not affect anagen development in the tylotrich (primary) HF (Fig. 4) , which make up ϳ5-10% of all HF in mouse dorsal skin and are characterized by a large hair bulb, long straight hair, and two sebaceous glands (51, 55) . This is not surprising, because it was recently shown that the induction of tylotrich and non-tylotrich HF in embryonic skin requires differential molecular pathways. Whereas induction of the tylotrich HF is strikingly 
arrowheads). E-H) Lef-1 immunoreactivity. E, F)
Control telogen/anagen I and anagen VI skin. Positive immunostaining in the dermal papilla and secondary hair germ of the telogen/anagen I HF (E, arrow and arrowhead, respectively) and in the hair matrix and precortical zone of the anagen VI HF (F, arrows) . G) BMP4-treated skin. Lef-1 immunoreactivity in the precortical zone, matrix (arrows), and the dermal papilla of tylotrich anagen VI HF (arrowhead). H) Noggin-treated skin. Positive immunostaining in the hair matrix of anagen VI HF (arrows). Abbreviations: DP, dermal papilla; EP, epidermis; HM, hair matrix; Mel, melanin; ORS, outer root sheath; SHG, secondary hair germ. Scale bars: 100 m. dependent on signaling through the newly identified TNF receptor homologue Edar, the induction of the non-tylotrich HF is Edar independent and most likely occurs via activation of the Wnt/␤-catenin/Lef-1 pathway (56) . This would be consistent with a recent observation that ␤-catenin acts downstream of Eda/Edar and upstream of BMP during placode formation (57) .
In turn, the Wnt pathway represents an important target for BMP regulation, because excess BMP signaling in noggin knockout mice results in down-regulation of the Lef-1 transcription factor and noggin overexpression leads to the ectopic Lef-1 expression in the HF (33, 36) . We have recently shown that constitutive deletion of the BMP antagonist noggin selectively affects induction of the non-tylotrich (secondary) HF in embryonic skin (58; V. A. Botchkarev et al., unpublished results). This supports a concept that Edar and Wnt/Lef-1 signaling pathways at certain stages of development are regulated independently of each other (56, 59) .
However, the molecular basis of the differential response of tylotrich vs. non-tylotrich HF to BMP4 stimulation remains to be dissected. We found no differences in the expression of BMP4, BMPR-IA, noggin, ␤-catenin, Lef-1, and Shh between tylotrich and non-tylotrich HF in the postnatal skin. This is consistent with data obtained from embryonic skin where tylotrich (primary) and non-tylotrich (secondary) HF were characterized by the essentially similar expression patterns of BMP4, BMPR-IA, and Shh (33, 41, 56, 60) . It remains to be elucidated whether Edar and its ligand ectodysplasin are expressed in postnatal HF and whether signaling through Edar induces anagen development in tylotrich HF.
In animals with a synchronized pattern of HF cycling, such as mice and rats, anagen develops spontaneously as a wave, which is propagated from anagen skin areas to neighboring telogen skin (3, 11, 61) . It is now well appreciated that actively growing HF secrete growth factors into the skin and induce substantial remodeling of skin architecture, innervation, and microvasculature (38, 39, 62, 63) . Therefore, it was logical to expect that anagen HF secretes factor(s) capable of inducing anagen phase in neighboring telogen HF.
Shh is one such candidate anagen inducer, since temporarily overexpressed Shh induces anagen in telogen mouse skin and Shh-neutralizing antibody inhibits anagen development (27, 28) . However, as we show here, Shh is produced by the unilateral cluster of hair matrix keratinocytes only in the anagen VI HF (Fig. 5) . This renders it rather unlikely that Shh, secreted by late anagen HF, significantly influences the closely located telogen HF to also enter into anagen.
Our data suggest that the BMP antagonist noggin is at least one other candidate signaling molecule for anagen wave propagation. Noggin is also expressed in the late anagen HF and is a potent anagen inducer in vivo (Fig. 2, Fig. 3 ). In contrast to Shh, noggin is abundantly expressed not only in the dermal papilla, but also in the epithelium of the cyclic portion of late anagen HF, as well as in numerous connective tissue cells surrounding HF (Fig. 2) . Noggin expression in follicular epithelium may in turn be controlled by BMP4, known to positively regulate noggin in other models (64, 65) via its interaction with BMPR-IA (Fig.  2) . This invites the hypothesis that a gradient of noggin, secreted by anagen HF and perifollicular mesenchymal cells, neutralizes the anagen inhibitory activity of BMPs and initiates transition of the telogen HF to anagen (Fig. 6) .
Most important, our data suggest that the anageninducing effect of noggin is mediated at least in part by activation of Shh signaling in the HF. We show that Shh is up-regulated in the HF after noggin treatment, whereas BMP4 down-regulates Shh (Fig. 5) . This suggests a model in which noggin neutralizing BMPs represent important upstream effectors of Shh during activation of hair growth in non-tylotrich telogen HF (Fig. 6) . Although the expression patterns of Shh receptors Patched-1/2 during noggin-induced HF telogen-anagen transition remain to be elucidated, this model is consistent with recently published observations that excess BMP4 antagonizes Shh signaling during tooth and limb development (66, 67) . However, the possible interactions of BMP signaling with other pathways implicated in anagen induction (e.g., estrogen receptor signaling or the STAT3 pathway; 15, 19, 68) remain to be carefully dissected.
Taken together, our data suggest that the molecular mechanisms that direct HF induction in embryonic skin and initiate anagen during postnatal HF cycling show striking similarities and are more highly conserved than previously appreciated. Our study encourages exploration of BMP antagonists for anagen manipulation in human skin affected by hair growth disorders (androgenetic alopecia, alopecia areata, telogen effluvium), all of which are characterized by elongation of telogen and shortening of anagen (2, 22) .
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